Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Caribou Biosciences reported a quarterly loss of $0.46 per share, missing estimates. - The company's revenues for the quarter ended March 2024 were $2.43 million, missing estimates. - Caribou Biosciences shares have lost about 33.2% since the beginning of the year. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- Caribou Biosciences reported a quarterly loss of $0.46 per share, missing estimates.
- The company's revenues for the quarter ended March 2024 were $2.43 million, missing estimates.
- Caribou Biosciences shares have lost about 33.2% since the beginning of the year.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.